Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon

iPhone-only study increases trial population, pinpoints asthma symptom causes

Researchers have conducted a study solely through the iPhone using the Apple ResearchKit. Along with the Asthma Health mobile application, the study showcased how mobile devices can aide in large-scale clinical enrollment, secure data exchange through the app and collection of carious points of data. 

GPS, mobile app provide further insights into mental health

Psychology researchers are utilizing GPS to measure levels of depression and its effects on patients. A study, published in the Journal of Medical Internet Research, used GPS tracking and mobile applications to assess the correlation between daily experiences, continuous depression, anxiety and the tendency to become isolated.

Ubisoft, Ambloytech bring gaming to healthcare

Prescriptions for video games could be seen as a child’s dream medication—and now that dream could becoming reality. Amblyotech partnered with Ubisoft to develop the Amblyopad, a gaming system awaiting FDA approval to treat amblyopia.

Thumbnail

eConsult implementation increasing, improving specialty appointments

The implementation of eConsult systems are allowing patients to gain access to specialists and receiving more quickly, according to a study in Health Affairs that examined the benefits of eConsulting and specialty care.

Thumbnail

First-year residents will once again be able to work 24-hour shifts

The Accreditation Council for Graduate Medical Education (ACGME) has revised its limits on how long first-year residents can work in a single shift, increasing it from 16 to 24 hours, matching the maximum for residents at all levels.

Thumbnail

HIMSS sees path forward for IT policies in the age of Trump

While the policy talk among attendees at February's HIMSS 2017 in Orlando may have been focused on the Affordable Care Act (ACA)’s future, HIMSS’ own policy team was spotlighting opportunities to advance its legislative and regulatory wish list under a new Congress and President Donald Trump.

HIE reduces length of stay, readmission rates, demand on physicians

Health information exchange (HIE) can improve the quality of care and clinical workflow, according to a study testing its benefits. The study, "The Effects of Health Information Exchange Access on Healthcare Quality and Efficiency: An Empirical Investigation," examined how using HIE gives physicians a full view of patient’s health—and how these insights lead to better care.

Researchers improve monitoring, measurements of 'organs-on-chips'

Researchers at Brigham and Women's Hospital in Boston have improved monitoring capabilities of "organs-on-chips," minature structures that use living cells to mimic the function of organs. The new platform includes a biochemical sensor for continuous and accurate monitoring of substances released from the organ chip.

Displaying 2041 - 2048 of 3584

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup